Recall Record

Polepally, Jadcherla, N/A, India

Shilpa Medicare Limited recalls

2 recalls recorded since 2018, most recently on 29 July 2026. 1 is listed as ongoing. Status and classification are as published by the FDA.

Recalls2
Ongoing (FDA)1
Terminated or completed1
Class I (FDA)0

Ongoing Class II Drugs

Recall started
29 July 2026
Reason
Discolored solution. The firm has received market complaints reporting green to dark green discoloration in certain vials
Distribution
Nationwide in the USA.
Initiated
Voluntary: Firm initiated
Recall numbers
D-0764-2026, D-0765-2026

Terminated Class II Drugs

Recall started
8 December 2020
Terminated
11 March 2022
Reason
CGMP Deviations
Distribution
Nationwide in the U.S.
Initiated
Voluntary: Firm initiated
Recall numbers
D-0122-2021, D-0125-2021, D-0123-2021, D-0126-2021, D-0121-2021, D-0124-2021

A terminated FDA recall means the FDA has determined that all reasonable efforts to remove or correct the product have been made. What statuses mean.